Cochrane Abstracts
Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease: Cochrane systematic review
Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Recombinant Human Insulin-like Growth Factor I (rhIGF-I) for the Treatment of Amyotrophic Lateral Sclerosis/motor Neuron Disease: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433263/all/Recombinant_human_insulin_like_growth_factor_I__rhIGF_I__for_the_treatment_of_amyotrophic_lateral_sclerosis_motor_neuron_disease:_Cochrane_systematic_review. Accessed 01 August 2021.
Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433263/all/Recombinant_human_insulin_like_growth_factor_I__rhIGF_I__for_the_treatment_of_amyotrophic_lateral_sclerosis_motor_neuron_disease:_Cochrane_systematic_review. Accessed August 1, 2021.
Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433263/all/Recombinant_human_insulin_like_growth_factor_I__rhIGF_I__for_the_treatment_of_amyotrophic_lateral_sclerosis_motor_neuron_disease:_Cochrane_systematic_review
Recombinant Human Insulin-like Growth Factor I (rhIGF-I) for the Treatment of Amyotrophic Lateral Sclerosis/motor Neuron Disease: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2021 August 01]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433263/all/Recombinant_human_insulin_like_growth_factor_I__rhIGF_I__for_the_treatment_of_amyotrophic_lateral_sclerosis_motor_neuron_disease:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease: Cochrane systematic review
ID - 433263
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433263/all/Recombinant_human_insulin_like_growth_factor_I__rhIGF_I__for_the_treatment_of_amyotrophic_lateral_sclerosis_motor_neuron_disease:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
